Clinical and imaging evolution of anti‐ GAD65 ‐associated epilepsy
- 18 June 2026
- journal article
- case report
- Published by Wiley in Epileptic Disorders
- Vol. 28 (5) , 1723-1726
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cognitive decline in adult-onset temporal lobe epilepsy: Insights from aetiologyClinical Neurology and Neurosurgery, 2024
- Antibody Prevalence in Epilepsy before Surgery (APES) in drug‐resistant focal epilepsyEpilepsia, 2021
- Antibodies Contributing to Focal Epilepsy Signs and Symptoms ScoreAnnals of Neurology, 2021
- Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune‐associated epilepsy: Conceptual definitionsEpilepsia, 2020
- Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase AntibodiesFrontiers in Neurology, 2019
- Autoimmune epilepsy: findings on MRI and FDG-PETBritish Journal of Radiology, 2018
- Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunctionJournal of Neuroimmunology, 2018
- Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic DrugsFrontiers in Neurology, 2018
- Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsyEpilepsy & Behavior, 2018
- Antithyroid antibodies as a potential marker of autoimmune-mediated late onset temporal lobe epilepsyClinical Neurology and Neurosurgery, 2014